Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Koch's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06613919
What this trial is testing

Six-months Versus Nine-months ATT for Ocular TB

Who this might be right for
Tuberculosis (TB)UveitisRetinal Vasculitis+1 more
L.V. Prasad Eye Institute 58
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Not applicableStudy completedNCT00134342
What this trial is testing

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

Who this might be right for
Tuberculosis
University Health Network, Toronto 203
Not applicableStudy completedNCT01608685
What this trial is testing

Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients

Who this might be right for
Latent Tuberculosis Infection
Ligue Pulmonaire Genevoise 205
Not applicableUnknownNCT00608790
What this trial is testing

Rapid Diagnosis of Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
University of Cape Town 600
Testing effectiveness (Phase 2)Study completedNCT02712424
What this trial is testing

DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

Who this might be right for
Tuberculosis
Dartmouth-Hitchcock Medical Center 625
Not applicableUnknownNCT04232618
What this trial is testing

Point-of-care Triage Test for Active Tuberculosis

Who this might be right for
TuberculosisTuberculosis, Pulmonary
University of Stellenbosch 900
Not applicableStudy completedNCT01087190
What this trial is testing

Isoniazid (INH) Treatment Based on ELISPOT Assay

Who this might be right for
Kidney Transplant Recipient
Asan Medical Center 831
Not applicableLooking for participantsNCT07628140
What this trial is testing

Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission

Who this might be right for
Tuberculosis PreventionHIV
University of Washington 1,500
Not applicableStudy completedNCT02135289
What this trial is testing

The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID

Who this might be right for
Inflammatory Bowel DiseaseCrohn DiseaseUlcerative Colitis+2 more
Chinese University of Hong Kong 9,160
Testing effectiveness (Phase 2)Study completedNCT00397943
What this trial is testing

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Who this might be right for
Tuberculosis
GlaxoSmithKline 110
Early research (Phase 1)Study completedNCT04525235
What this trial is testing

Phenotyping of High Dose Rifampicin

Who this might be right for
Tuberculosis
Radboud University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT03557281
What this trial is testing

An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 76
Not applicableStudy completedNCT04857814
What this trial is testing

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases

Who this might be right for
Progressive Fibrosing Interstitial Lung DiseaseLung TransplantCystic Fibrosis+2 more
University of Alberta 8
Early research (Phase 1)Study completedNCT01674218
What this trial is testing

Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 74
Not applicableStudy completedNCT03918226
What this trial is testing

Acute Presentation and Management of Abdominal Tuberculosis: A Ten-year Experience at a Tertiary Care Center in Pakistan

Who this might be right for
Tuberculosis; Abdomen
Services Hospital, Lahore 80
Post-approval studies (Phase 4)Ended earlyNCT01329250
What this trial is testing

Pharmacokinetics and Safety of Moxifloxacin

Who this might be right for
Tuberculosis
University Medical Center Groningen 9
Not applicableStudy completedNCT00170638
What this trial is testing

Tuberculosis Immunity in Children

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 260
Testing effectiveness (Phase 2)Study completedNCT02415985
What this trial is testing

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Who this might be right for
HIVTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07076225
What this trial is testing

Ultra-Short Regimen for Elderly DS-TB

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 300
Next Page